Embedded Files
LOW risk for bleeding
LOW risk for bleeding
Withholding
Withholding
Do not withhold
Reinitiation
Reinitiation
Not applicable
HIGH risk for bleeding
HIGH risk for bleeding
Withholding
Withholding
4 doses if CrCl ≥ 50 mL/min
6-8 doses if CrCl < 30–50 mL/min
If procedure is STAT or emergent, use reversal agent (idarucizumab)
Consider checking thrombin time or dabigatran level with impaired renal function
Reinitiation
Reinitiation
24 hours
Page updated
Google Sites
Report abuse